Skip to main content
Fig. 4 | BMC Musculoskeletal Disorders

Fig. 4

From: Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy

Fig. 4

qPCR analyses show changes in the expression of key markers for bone metabolism. Abbreviations in order: Runt related transcription factor 2, Type I collagen, Osteopontin, Dentin matrix protein 1, Sclerostin, Dickkopf-related protein 1, Receptor activator of nuclear factor kappa-B ligand, Osteoprotegerin, Tartrate resistant acid phosphatase, Cathepsin K. N = 6-7 per group. * = p ≤ 0.05 compared to PBS group

Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us